Form 4 Tracker
Richard A. Heyman

Director · 7 filings · Latest: Oct 1, 2026

Enliven Therapeutics, Inc.
Oric Pharmaceuticals, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
ORIC
Richard A. HeymanDirectorOct 1, 2026
Sale
$12.916,700$86.5K203,472
ORIC
Richard A. HeymanDirectorOct 1, 2026
Option Exercise
$1.603,500$5.6K41,800
ORIC
Richard A, Heyman—Oct 1, 2026
Proposed Sale
$13.478,100$109.1K—
ORIC
Richard A, Heyman—Oct 1, 2026
Proposed Sale
$13.477,600$102.4K—
ELVN
Heyman Richard A.—Sep 4, 2026
Proposed Sale
$59.2938,000$2.3M—
ORIC
Richard A. HeymanDirectorJul 24, 2026
Sale
$12.0213,100$157.5K206,672
ORIC
Richard A. HeymanDirectorJul 24, 2026
Option Exercise
$1.603,500$5.6K45,300
ORIC
Richard A. HeymanDirectorJul 6, 2026
Sale
$12.00300$3.6K212,772
ORIC
Richard A, Heyman—Jul 6, 2026
Proposed Sale
$12.007,000$84.0K—
ORIC
Richard A, Heyman—Jul 6, 2026
Proposed Sale
$12.006,400$76.8K—
ELVN
Richard A. HeymanDirectorFeb 17, 2026
Sale
$26.181,230$32.2K22,647
ELVN
Heyman Richard A.—Feb 17, 2026
Proposed Sale
$26.721,230$32.9K—
ELVN
Richard A. HeymanDirectorJan 20, 2026
Sale
$26.751,230$32.9K23,877
ORIC
Richard A. HeymanDirectorJan 16, 2026
Sale
$12.006,700$80.4K213,072
ELVN
Heyman Richard A.—Jan 20, 2026
Proposed Sale
$26.711,230$32.9K—
ORIC
Richard A, Heyman—Jan 16, 2026
Proposed Sale
$12.006,400$76.8K—
ORIC
Richard A, Heyman—Jan 16, 2026
Proposed Sale
$12.007,000$84.0K—
ELVN
Heyman Richard A.—Jan 8, 2026
Proposed Sale
$15.471,620$25.1K—
ELVN
Heyman Richard A.—Jan 8, 2026
Proposed Sale
$15.4712,300$190.3K—
ELVN
Heyman Richard A.—Oct 18, 2024
Proposed Sale
$28.021,566$43.9K—

Page 1 of 2

Next →